SS Innovations International, Inc. (Nasdaq: SSII) announced today that its SSi Mantra surgical robotic system has been used in more than 10,500 cumulative surgeries as of April 30, 2026, marking a significant milestone for the company and the field of robotic surgery. The system, which was commercially launched in August 2022, has been adopted across 11 countries with over 200 installed systems, according to the company's press release.
The 10,500-plus procedures include more than 500 cardiac surgeries, 170 telesurgeries, and 125 pediatric operations. Additionally, approximately 2,100 physicians have been trained on the SSi Mantra, which has been utilized for over 170 different types of procedures. Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, credited the system's advanced technology, ease of training, and cost advantages for its rapid uptake. "Reaching 10,500 cumulative surgeries in such a short time span reflects the SSi Mantra’s advanced technology, differentiated features, ease of training, user-friendliness, and clear cost advantages," Dr. Srivastava said in the announcement. He also emphasized the company's mission to "democratize access to world-class surgical robotic care."
The milestone underscores the growing role of robotic surgery in making minimally invasive procedures more accessible, particularly in emerging markets. The SSi Mantra's modular design—featuring 3 to 5 robotic arms, an open-faced surgeon console, and a 3D 4K display—is tailored for multi-specialty use, including cardiac, pediatric, and ENT surgeries. The system also supports telesurgery via the SSi MantrAsana Tele Surgeon Console, which enables remote procedures, a capability that could expand surgical access to underserved regions.
The implications for the healthcare industry are substantial. Robotic surgery typically offers benefits such as reduced recovery times, lower complication rates, and enhanced precision. However, high costs have limited its adoption. SS Innovations positions the SSi Mantra as a cost-effective alternative, potentially lowering barriers for hospitals and clinics. With over 10,500 surgeries performed and a growing installed base, the system is gaining clinical validation, which could accelerate its adoption in new markets and specialties.
For investors, the milestone signals strong commercial momentum for SS Innovations, which trades under the ticker $SSII. The company's newsroom provides updates at https://tinyurl.com/ssiinewsroom. As the company expands its global footprint, the impact could extend to patients worldwide, offering access to advanced surgical care that was previously out of reach. The SSi Mantra's ability to perform over 170 procedure types and its training of 2,100 physicians suggest a growing ecosystem that could further drive adoption and improve surgical outcomes.
